Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Identification of a Novel Nucleoside Prodrug with Preferential Activity in Lymphoma and Leukemia Subtypes

Marissa L Calbert, Gurushankar Chandramouly, Tatiana Kent, Clare M Adams, Mrityunjay Tyagi, Yifan Wang, John Krais, Hoora Shaghaghi, Jessica Atkins, Tomasz Skorski, Neil Johnson, Christine M Eischen, Richard Pomerantz

Blood (2022) 140 (Supplement 1): 10701.

https://doi.org/10.1182/blood-2022-165514

Published: 2022

Journal Articles

Bclw Overexpression Predicts Aggressive Disease in B-Cell Lymphomas

Amanda McBride, MD PhD, Clare M Adams, PhD, Ramkrishna Mitra, PhD, Christine M Eischen, PhD

Blood (2020) 136 (Supplement 1): 29.

https://doi.org/10.1182/blood-2020-142545

Published: 2020

Journal Articles

Loss of the DNA Fork Remodeling Protein Smarcal1 Impairs the Replication Stress Response in Proliferating Hematopoietic Cells

Saul Kushinsky, BS, Matthew V Puccetti, MDPhD, Clare M Adams, PhD, Christine M Eischen, PhD

Blood (2020) 136 (Supplement 1): 34.

https://doi.org/10.1182/blood-2020-140354

Published: 2020

Journal Articles

Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides

Laura Y. McGirt, Peilin Jia, Devin A. Baerenwald, Robert J. Duszynski, Kimberly B. Dahlman, John A. Zic, Jeffrey P. Zwerner, Donald Hucks, Utpal Dave, Zhongming Zhao, Christine M. Eischen

Blood (2015) 126 (4): 508–519.

https://doi.org/10.1182/blood-2014-11-611194

Published: 2015

Includes: Supplemental data

Journal Articles

PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells

Sung Hoon Cho, Shreevrat Goenka, Tiina Henttinen, Prathyusha Gudapati, Arja Reinikainen, Christine M. Eischen, Riitta Lahesmaa, Mark Boothby

Blood (2009) 113 (11): 2416–2425.

https://doi.org/10.1182/blood-2008-03-144121

Published: 2009

Includes: Supplemental data

Journal Articles

Comparison of Apoptosis in Wild-Type and Fas-Resistant Cells: Chemotherapy-Induced Apoptosis Is Not Dependent on Fas/Fas Ligand Interactions

Christine M. Eischen, Timothy J. Kottke, Luis M. Martins, Guriqbal S. Basi, Jay S. Tung, William C. Earnshaw, Paul J. Leibson, Scott H. Kaufmann

Blood (1997) 90 (3): 935–943.

https://doi.org/10.1182/blood.V90.3.935

Published: 1997

NARROW

Identification of a Novel Nucleoside Prodrug with Preferential Activity in Lymphoma and Leukemia Subtypes

Bclw Overexpression Predicts Aggressive Disease in B-Cell Lymphomas

Loss of the DNA Fork Remodeling Protein Smarcal1 Impairs the Replication Stress Response in Proliferating Hematopoietic Cells

Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides

PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells

Comparison of Apoptosis in Wild-Type and Fas-Resistant Cells: Chemotherapy-Induced Apoptosis Is Not Dependent on Fas/Fas Ligand Interactions

Email alerts

ASH Publications

American Society of Hematology

Identification of a Novel Nucleoside Prodrug with Preferential Activity in Lymphoma and Leukemia Subtypes

Bclw Overexpression Predicts Aggressive Disease in B-Cell Lymphomas

Loss of the DNA Fork Remodeling Protein Smarcal1 Impairs the Replication Stress Response in Proliferating Hematopoietic Cells

Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides

PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells

Comparison of Apoptosis in Wild-Type and Fas-Resistant Cells: Chemotherapy-Induced Apoptosis Is Not Dependent on Fas/Fas Ligand Interactions

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only